Prevalence of inadequate glycemic control among patients with type 2 diabetes in the United Kingdom general practice research database: A series of retrospective analyses of data from 1998 through 2002

Clinical Therapeutics

Volumn 28, Issue 3, 2006, Pages 388-395

  Fox, Kathleen M ^a   Gerber PharmD, Robert A ^b   Bolinder, Bjorn ^c   Chen, Jack ^d   Kumar, Sanjaya ^d  

^a Strategic Healthcare Solutions LLC   (United States)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

^c SANOFI   (France)

^d Quantros Inc   (United States)

Author keywords

diabetes complications; glycemic control; GPRD; inadequate control; oral antidiabetic therapy; type 2 diabetes

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN; HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT; ANTIDIABETIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DATA ANALYSIS; DATA BASE; DISEASE CONTROL; EVALUATION; FEMALE; FOLLOW UP; GENERAL PRACTICE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RESEARCH; PREVALENCE; RETROSPECTIVE STUDY; SEX RATIO; STATISTICAL ANALYSIS; TREATMENT OUTCOME; UNITED KINGDOM; AGE; BODY MASS; CROSS-SECTIONAL STUDY; MIDDLE AGED; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; DATABASES; DIABETES MELLITUS, TYPE 2; FAMILY PRACTICE; FEMALE; GREAT BRITAIN; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES;

EID: 33745631544     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2006.03.005     Document Type: Article

References (32)

1. Albright E. The diabetes epidemic. Ala Diabetes Monitor 1 (2002) 1-2
2. Available at:. International Diabetes Federation. Diabetes atlas. Accessed (June 29, 2005). http://www.eatlas.idf.org
3. [press release]. Available at:. American Diabetes Association. Pre-diabetes is serious, costly, and a big CVD risk. Accessed (June 11, 2005). http://www.diabetes.org/uedocuments/PrediabetesCostly.pdf
4. Klein R., Klein B.E., and Moss S.E. Relation ofglycemic control to diabetic microvascular complications in diabetes mellitus. Ann Intern Med 124 (1996) 90-96
5. Kuusisto J., Mykkanen L., Pyorala K., and Laakso M. NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes 43 (1994) 960-967
6. Klein R. Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care 18 (1995) 258-268
7. Khaw K.T., Wareham N., Luben R., et al. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk). BMJ 322 (2001) 15-18
8. Kereiakes D.J. Myocardial infarction in the diabetic patient. Clin Cardiol 8 (1985) 446-450
9. Miettinen H., Lehto S., Salomaa V., et al., FINMONICA Myocardial Infarction Register Study Group. Impact of diabetes on mortality after the first myocardial infarction. Diabetes Care 21 (1998) 69-75
10. McAlpine R.R., Morris A.D., Emslie-Smith A., et al. The annual incidence of diabetic complications in a popu lation of patients with type 1 and type 2 diabetes. Diabet Med 22 (2005) 348-352
11. Jerums G., and Maclsaac R.J. Treatment of microalbuminuria in patients with type 2 diabetes mellitus. Treat Endocrinol 1 (2002) 163-173
12. Wilde C. Diabetic nephropathy-who cares?. EDTNA ERCAJ 30 (2004) 163-165
13. Nathan D.M. Clinical practice. Initial management of glycemia in type 2 diabetes mellitus. N Engl J Med 347 (2002) 1342-1349
14. Marre M. Before oral agents fail: The case for starting insulin early. Int J Obes Relat Metab Disord 26 Suppl 3 (2002) S25-S30
15. Piwernetz K., Home P.D., Snorgaard O., et al., DIABCARE Monitoring Group of the St. Vincent Declaration Steering Committee. Monitoring the targets of the St. Vincent Declaration and the implementation of quality management in diabetes care: The DIABCARE initiative. TheDIABCARE Monitoring Group of the St Vincent Declaration Steering Committee. Diabet Med 10 (1993) 371-377
16. Stratton I.M., Adler A.I., Neil H.A., et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study. BMJ 321 (2000) 405-412
17. United Kingdom Prospective Diabetes Study Group. United Kingdom Prospective Diabetes Study 24: A 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy. Ann Intern Med 128 (1998) 165-175
18. European Diabetes Policy Group 1999. A desktop guide to type 2 diabetes mellitus. Diabet Med 16 (1999) 716-730
19. Available at:. Royal College of General Practitioners, Effective Clinical Practice Unit, University of Sheffield. Clinical guidelines for type 2 diabetes: Management of blood glucose. Accessed (June 21, 2005). http://www.nice.org.uk/pdf/NICE_full_blood_glucose.pdf
20. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 28 Suppl 1 (2005) S4-S36
21. Available at:. General Practice Research Database Web site. Accessed (November 4, 2005). http://www.gprd.com/home
22. Garcia Rodriguez L.A., and Perez Gutthann S. Use of the UK General Practice Research Database for pharmaco epidemiology. Br J Clin Pharmacol 45 (1998) 419-425
23. Jick H., Jick S.S., and Derby L.E. Validation of information recorded on general practitioner based computerized data resource in the United Kingdom. BMJ 302 (1991) 766-768
24. Jick H., Terris B.Z., Derby L.E., and Jick S.S. Further validation of information recorded on a general practitioner based computerized data resource in the United Kingdom. Pharmacoepidemiol Drug Saf 1 (1992) 347-349
25. Jick S.S., Kaye J.A., VasilakisScaramozza C., et al. Validity of the general practice research database. Pharmacotherapy 23 (2003) 686-689
26. Casella G., and Berger R.L. Statistical Inference. 2nd ed. (2002), Thompson Learning, Pacific Grove, Calif.
27. Saunders S.A., Wallymahmed M., and MacFarlane I.A. Glycaemic control in a type 1 diabetes clinic for younger adults. QJM 97 (2004) 575-580
28. [published correction appears in Lancet. 1999; 354:602]. UK Prospective Diabetes Study (UKPDS) Group. Intensive bloodglucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 (1998) 837-853
29. Maizlish N.A., Shaw B., and Hendry K. Glycemic control in diabetic patients served by community health centers. Am J Med Qual 19 (2004) 172-179
30. Currie C.J., Morgan C.L., Dixon S., et al. The financial costs of hospital care for people with diabetes who have single and multiple macrovascular complications. Diabetes Res Clin Pract 67 (2005) 144-151
31. Lange L.J., and Piette J.D. Perceived health status and perceived diabetes control: Psychological indicators and accuracy. J Psychosom Res 58 (2005) 129-137
32. Savoca M.R., Miller C.K., and Quandt S.A. Profiles of people with type 2 diabetes mellitus: The extremes of glycemic control. Soc Sci Med 58 (2004) 2655-2666